BASKING RIDGE, N.J. – electroCore, a bioelectronic medicine company, has launched the gammaCore Sapphire, a non-invasive vagus nerve stimulator (nVNS) device to treat the pain associated with migraine and episodic cluster headaches. gammaCore Sapphire can be self-administered by patients as needed for the pain associated with migraine and episodic cluster headaches. “Constantly innovating to deliver the next-generation device is just one example of our commitment to providing relief to patients suffering from the debilitating pain of migraine and episodic cluster headache,” said Dan Duhart, chief commercial officer of electroCore, in a statement. gammaCore Sapphire is rechargeable and reloadable, and can be activated monthly through the input of a unique, prescription-only authorization code, delivered via a radio-frequency identification (RFID) card that is mailed directly to the patient.
You are here: / / gammaCore launched in US